Drug-related deaths have more than doubled worldwide since 1990, despite an 8% drop in new addiction cases, according to a comprehensive analysis published in Frontiers in Psychiatry.

The paradoxical findings expose critical failures in global harm-reduction and recovery systems.

Global drug mortality rates surge in wealthy nations

Between 1990 and 2021, global drug mortality rates increased by 122%, reaching 137,278 deaths annually. Age-adjusted mortality rose by 31% to 1.65 per 100,000 people.

High-income North America experienced the most dramatic increase, with an 11.2-fold rise in deaths from 6,125 to 74,451 annually. The United States, particularly states such as West Virginia, remains severely affected.

Disability-adjusted life years increased by 75% globally to 15.6 million, with the rise greatest in wealthiest countries.

Opioids drive mortality crisis

Opioids caused deaths to rise 39%, primarily in wealthy developed regions. The surge stems from pharmaceutical deregulation, aggressive marketing and regulatory failures to limit access to highly addictive drugs.

Cocaine deaths more than doubled, with researchers noting that cocaine and opioids are frequently co-used with potentially synergistic toxicity.

Men aged 20-24 years faced 35% higher risk than women. The highest proportion of deaths occurred between ages 25 and 29.

The study authors emphasise that prevention alone proves insufficient, calling for integrated strategies combining harm reduction, treatment access and long-term management to tackle rising global drug mortality rates.

Read the full study analysis at News Medical